4//SEC Filing
Chadwick Jeremy G 4
Accession 0000950170-23-023515
CIK 0001815442other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 7:35 PM ET
Size
7.2 KB
Accession
0000950170-23-023515
Insider Transaction Report
Form 4
Chadwick Jeremy G
Chief Operating Officer
Transactions
- Award
Common Stock
2023-05-22+33,333→ 33,333 total - Award
Stock Option (Right to Buy)
2023-05-22+200,000→ 200,000 totalExercise: $29.64Exp: 2023-05-22→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following May 22, 2023, subject to the reporting person's continued employment through each vesting date.
- [F2]25% of the shares underlying this stock option shall vest on May 22, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001388406
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 7:35 PM ET
- Size
- 7.2 KB